Cleaning the Biopsy Needle in TRUS Bx

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorHitit University

About this trial

Prostate cancer(PCa) is the second most common cancer diagnosed in men. Clinical suspicion of PCa is mentioned in patients with digital rectal examination findings and elevated serum PSA. Despite all the advances in radiological imaging methods, the gold standard method in the diagnosis of the disease is systematic prostate biopsy performed under the guidance of transrectal ultrasonography, which is an invasive procedure.

In TRUS-guided transrectal prostate biopsy, bacteriuria may develop as a result of the rectum flora being injected into the urinary system through a biopsy needle. Infective complications may be encountered as a result of this contamination. Infective complications can present with conditions ranging from asymptomatic bacteriuria to sepsis.

A study has shown that disinfection of the biopsy needle with isopropyl alcohol reduces sepsis due to prostate biopsy compared to the standard procedure. In another study, disinfection of the biopsy needle tip with formalin was found to be associated with a decrease in infectious complications after transrectal prostate biopsy.

In this study, investigators aimed to conduct a prospective study comparing Transrectal Ultrasonography-guided Prostate Biopsy cases, in which the biopsy needle was cleaned with isopropyl alcohol, povidone iodine and formalin, and standard biopsy patients in terms of infectious complications.

Eligibility criteria

Qualifiers

Oriented-coopere patients

Patients without active urinary tract infection - Patients without active urinary tract infection

Patients without bleeding diathesis

Patients who accept the study

Disqualifiers

Patients with active urinary tract infection

Patients with bleeding diathesis

Patients with sonal or cystofix

Patients with a history of previous prostate surgery

Trial design

Treatments tested in this trial

  • Isopropyl Alcohol
  • Povidine-iodine
  • formaldehit
  • Standard BP control

Treatment groups

200 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators